← Back to headlines
Takeda's Entyvio Label Expansion for Children Under FDA Review
Takeda's application for an expanded label for its drug Entyvio, to include use in children, is currently under review by the FDA.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
